Peloton Announces Q2 FY2026 Financial Results
Globenewswire· 2026-02-05 12:00
Delivered Year-over-Year Improvement in Profitability While Investing in Ambitious Innovation Agenda Raises Full Year FY2026 Adjusted EBITDA Guidance to $450 - $500 million* NEW YORK, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Peloton Interactive, Inc. today reported financial results for the quarter ended December 31, 2025. Q2 FY2026 Financial Highlights Ending Paid Connected Fitness Subscriptions were 2.661 million, a decrease of 214,000 or 7% year-over-year and 6,000 above the midpoint of our guidance range. We o ...
Boundless Bio to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Globenewswire· 2026-02-05 12:00
SAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with previously intractable oncogene amplified cancers, today announced that Zachary Hornby, President and Chief Executive Officer, will participate in a fireside chat at the Guggenheim Emerging Outlook: Biotech Summit 2026. The fireside chat session is scheduled for Thursday, February 12, in New York, ...
First Advantage to Release Fourth Quarter and Full Year 2025 Financial Results and Hold Investor Conference Call on February 26, 2026
Globenewswire· 2026-02-05 12:00
ATLANTA, Feb. 05, 2026 (GLOBE NEWSWIRE) -- First Advantage Corporation (NASDAQ: FA), a leading provider of global software and data in the HR technology industry, will issue its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 prior to the Company’s earnings conference call, which will be held at 8:30 a.m. ET on the same day. Conference Call Details To participate in the conference call, please dial 800-225-9448 (domestic) or 203-518-9708 (international) approximately ten m ...
Can-Fite: Patient with Decompensated Liver Cirrhosis Successfully Undergoes Liver Transplantation Following Treatment with Namodenoson
Globenewswire· 2026-02-05 12:00
Namodenoson Provided Clinical Stabilization as a Potential Bridge to Transplant in Advanced Liver Failure Ramat Gan, Israel, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company developing a pipeline of proprietary small molecule drugs targeting oncological and inflammatory diseases, today announced that a patient with advanced decompensated liver cirrhosis who was treated with Namodenoson subsequently underwent a successful liver transplantat ...
Electra to Participate in Industry Conferences Focused on Critical Minerals Supply Security
Globenewswire· 2026-02-05 12:00
TORONTO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Electra Battery Materials Corporation (NASDAQ: ELBM; TSX-V: ELBM) (“Electra” or the “Company”), a leader in advancing North America’s critical minerals processing, is pleased to announce that members of its executive leadership team will be participating in several key global mining, battery materials, and investment conferences in the coming weeks. Electra’s participation in these events supports the execution of the Company’s strategy to onshore North American cr ...
Broadwind Announces Preliminary Full-Year 2025 Results, Introduces Full-Year 2026 Financial Guidance, and Announces Fourth Quarter 2025 Results Conference Call and Webcast Date
Globenewswire· 2026-02-05 12:00
CICERO, Ill., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Broadwind (Nasdaq: BWEN, or the “Company”), a diversified precision manufacturer of specialized components and equipment serving global markets, today announced select preliminary financial results for the full-year 2025 ended December 31, 2025, and introduced financial guidance for the full-year 2026. PRELIMINARY FULL-YEAR 2025 RESULTS All listed ranges are an estimate, based on information available to management as of the date of this release, and are subj ...
MariMed’s Betty’s Eddies™ Introduces New Limited-Edition Valentine’s Seasonal, Berry In Love Betty
Globenewswire· 2026-02-05 12:00
The Brand’s First-Ever Swirled Chew Combines Strawberry and Chocolate Flavors Plus CBG and Horny Goat Weed for Libido-enhancing FunNORWOOD, Mass., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Betty’s Eddies™, the all-natural cannabis fruit chews handcrafted for specific health and wellness effects, is expanding its lineup with a new limited-edition batch of strawberry chocolate chews in time for Valentine’s Day: Berry In Love Betty. Betty’s Eddies is one of the top-selling and award-winning brands developed and distri ...
Kratos, NCSIST Team Successfully Test Integrated Mighty Hornet IV System
Globenewswire· 2026-02-05 12:00
Ultimate Objective is High Quantity Fleet of Mighty Hornet IV Systems Ready in Taiwan – Affordable MassSAN DIEGO, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leader in defense, national security and global markets, and the National Chung-Shan Institute of Science and Technology (NCSIST) today announced the successful test of the integrated Mighty Hornet IV Attack UAV, a revolutionary transformation of the MQM-178 Firejet target drone. Following the months of ...
Everbright Digital Holding Limited Announces 1-for-16 Reverse Share Split Effective February 9, 2026
Globenewswire· 2026-02-05 12:00
HONG KONG, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Everbright Digital Holding Limited (Nasdaq: EDHL) ("EDHL" or "we," "our," or the "Company"), an integrated marketing solutions provider headquartered in Hong Kong, today announced that on January 16, 2026, its board of directors approved a reverse split of its ordinary shares on a one-for-sixteen basis (the “Reverse Share Split”), and a change in par value of its ordinary shares from USD 0.00004 per share to USD 0.00064 par value per share. The Company’s ordinary ...
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
Globenewswire· 2026-02-05 12:00
SAN MATEO, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel therapeutics targeting dysfunctional metabolic and fibrotic pathways, today announced that management will participate in two upcoming investor conferences. Guggenheim Emerging Outlook: Biotech Summit 2026 in New York, NY, on February 11, 2026, with a fireside chat at 10am ET (link here).Oppenheimer 36th Annual Healthcare Life Sciences Conference on Februa ...